Method of treating amyotrophic lateral sclerosis
Abstract:
The present invention relates to the treatment of a sporadic ALS patient with oral fausdil at a dose of 180-240 mg/day. This results in an anticipated 25-50% reduction in the average decline over at least three months as measured using the revised ALS Functional Rating Scale.
Public/Granted literature
Information query
Patent Agency Ranking
0/0